The men’s skincare market has witnessed a surge in demand for anti-aging products, driven by a heightened awareness about aging and the efficacy of ingredients such as retinol, vitamin C, and ...
Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company developing tecarfarin, a new vitamin K antagonist (VKA) designed to improve anticoagulation for patients with ...